SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

FET is drawing attention amid a renewed move higher and broader interest in AI-focused crypto tokens, with traders pointing to Fetch.ais autonomous-agent theme and accumulating on pullbacks. The reaction is bullish but cautious: some see a breakout developing, while others say FET needs to clear resistance and remains vulnerable to Bitcoin and wider altcoin weakness.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

New RAMP 201 molecular-profiling and external-control analyses of Verastems avutometinib/defactinib combination in recurrent low-grade serous ovarian cancer are drawing attention, especially findings suggesting activity in KRAS wild-type patients. Traders debate whether the data could broaden the treatment opportunity, while some are frustrated that positive developments have not lifted the share price and remain focused on the VS-7375 clinical update.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WRD is drawing attention amid a steep share-price decline and bearish technical commentary, including concerns about a possible further breakdown. Traders are split between citing WeRides fleet and ADAS expansion and worrying that weak commercialization, ongoing losses, receivables and managements lack of clear execution evidence are undermining investor confidence.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention after a modest price push toward a key resistance level, with traders hoping it signals a breakout. Others view the move as another brief spike, citing prolonged sideways trading and weak performance compared with other crypto assets.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Roots Hyundai Secure+ rollout at Arizona dealerships, including six months of insurance with vehicle purchases or leases, is drawing attention. Bulls see an embedded-sales opportunity to add policyholders, while skeptics question the programs economics and reach and point to recent declines in policies in force and stalled growth.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarins steep slide to multi-year lows is driving a debate over whether its cash position and international Vascepa growth can offset generic pressure and weak confidence in management. Traders point to the pending LR-EtEPA patent process and EMT-2 trial results as possible catalysts, while skeptics question the patents prospects and the companys ability to turn either development into commercial value.

OpenAI

OpenAIs confidential IPO filing is driving attention, with traders anticipating a major public listing and speculating about its timing. Reactions are divided: some see the filing as a catalyst for OpenAI and related holdings, while others question its valuation, losses, and ability to reach the market soon.

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgos OpenAI-linked autonomous-lab resultshighlighted by claims of lower cell-free protein synthesis costsare driving interest as traders view them as validation of its AI-and-automation pivot. Bulls see potential in the platform, while skeptics question whether the technology will translate into revenue and overcome the companys execution and cash-burn concerns.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injectives proposed supply-squeeze update is drawing bullish attention, with traders saying it could double INJs deflation rate; recurring discussion also points to burns, staking, and the networks developer and revenue activity as reasons they consider it undervalued. Optimism about a reversal and ETF-related interest contrasts with concerns about the prolonged downtrend, while repeated promotion of Injective meme token Nonja is a prominent side conversation.

USELESS

USELESS is drawing attention for a volatile meme-coin rally and traders hopes for another breakout, with many touting dip-buying and alleged whale accumulation. Others point to failed resistance tests, profit-taking and the risk of further declines; the bullish price and market-cap claims remain speculative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


chloelangley1

Chloe Langley